DONECEPT

This brand name is authorized in Hong Kong SAR China, Ireland, Malta, Poland, Romania, South Africa, Tunisia.

Active ingredients

The drug DONECEPT contains one active pharmaceutical ingredient (API):

1	Donepezil UNII 3O2T2PJ89D - DONEPEZIL HYDROCHLORIDE
	Donepezil hydrochloride is a specific and reversible inhibitor of acetylcholinesterase, the predominant cholinesterase in the brain. Donepezil hydrochloride is in vitro over 1000 times more potent an inhibitor of this enzyme than of butyrylcholinesterase, an enzyme that is present mainly outside the central nervous system.
	Read more about Donepezil

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DONECEPT Film-coated tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06DA02	Donepezil	N Nervous system → N06 Psychoanaleptics → N06D Anti-dementia drugs → N06DA Anticholinesterases
Discover more medicines within N06DA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
HK	Department of Health Drug Office	60384, 60385
IE	Health Products Regulatory Authority	22107, 22122, 46991, 48653
MT	Medicines Authority	PI1330/01103A, PI1330/01104A, PI1438/03801A, PI1438/03802A
PL	Rejestru Produktów Leczniczych	100206980, 100207011, 100366821, 100386580, 100393723, 100457138, 100465169
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68084001, W68084002, W68084003, W68084004, W68084005, W68084006, W68084007, W68084008, W68084009, W68084010, W68084011, W68084012, W68084013, W68084014, W68084015, W68085001, W68085002, W68085003, W68085004, W68085005, W68085006, W68085007, W68085008, W68085009, W68085010, W68085011, W68085012, W68085013, W68085014, W68085015
TN	Direction de la Pharmacie et du Médicament	10243131, 10243132
ZA	Health Products Regulatory Authority	42/5.3/0490, 42/5.3/0491, 53/5.3/0046, 53/5.3/0047